See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Piramal Pharma Limited Announces Results for Q1FY26

Summary by PR Newswire
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, and health and wellness company, today announced its...

21 Articles

LatestlyLatestly
Right

Piramal Pharma Q1 Net Loss at Rs 82 Cr

Get latest articles and stories on Latest News at LatestLY. Piramal Pharma has reported a consolidated net loss of Rs 82 crore for the first quarter ended June 30, 2025. Latest News | Piramal Pharma Q1 Net Loss at Rs 82 Cr.

Read Full Article
The Courier ExpressThe Courier Express
+18 Reposted by 18 other sources
Center

Piramal Pharma Limited Announces Results for Q1FY26

MUMBAI, India, July 28, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, and health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June 2025.

·DuBois, United States
Read Full Article
CNHI NewsCNHI News

Piramal Pharma Limited Announces First Quarter Fiscal Year 2026 Results

MUMBAI, India, July 29, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, healthcare and wellness company, today announced its standalone and consolidated results for the first quarter (Q1)…

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources are Center
57% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Monday, July 28, 2025.
Sources are mostly out of (0)

Similar News Topics

Health icon

Health

Mumbai icon

Mumbai

News
For You
SearchBlindspotLocal